Neurent Medical
Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis.
€62.5MSeries C
Role not disclosedFH
Fountain Healthcare Partners
Activity from announced rounds
All recorded activity
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $134.2M 2 disclosed · full round size, not this investor’s share